Antipyrine metabolism in cancer patients.
The metabolism of antipyrine was studied in cancer patients. Antipyrine elimination might be decreased in cancer patients. Increase in antipyrine half-life is not primarily due to the presence of a tumor but rather to the nutritional status and liver function of an individual.
D000328:Adult; D000368:Aged; D000983:Antipyrine / Q000378:metabolism*; D001663:Bilirubin / Q000097:blood; D003404:Creatinine / Q000378:metabolism; D006801:Humans; D007700:Kinetics; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000378:metabolism*; D012709:Serum Albumin / Q000032:analysis; D013274:Stomach Neoplasms / Q000378:metabolism*
D012709:Serum Albumin; D003404:Creatinine; D001663:Bilirubin; D000983:Antipyrine